Nevertheless, further research are required to investigate the role of PNISR and HNRNPH1 on the development of PAH, and the expansion of the sample size is needed to validate the efficacy of PNISR and HNRNPH1 as biomarkers for PAH. This evidence concerns the gene HNRNPH1 and pulmonary arterial hypertension.